SecSonar.com

Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Xenetic Biosciences, Inc. (XBIO) is a Biotechnology company based in US with a market capitalization of $5.9M. Revenue grew 19.0% year-over-year and free cash flow was negative at -$2.3M. This page tracks XBIO's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 2 employees · IPO Jun 30, 2016

Valuation

Valuation & price

$3.04 · as of May 17, 2026 · -70.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.80

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$10.36$6.19$2.03Jul 25Dec 25Jul 26Jul 7, 25$3.65Jul 9, 25$4.11Jul 11, 25$3.98Jul 15, 25$3.74Jul 17, 25$3.69Jul 21, 25$3.65Jul 23, 25$3.63Jul 25, 25$3.60Jul 29, 25$3.55Jul 31, 25$3.24Aug 4, 25$3.20Aug 6, 25$2.91Aug 11, 25$2.76Aug 13, 25$2.99Aug 15, 25$2.86Aug 19, 25$2.82Aug 21, 25$2.82Aug 25, 25$2.86Aug 27, 25$2.84Aug 29, 25$2.85Sep 3, 25$3.04Sep 5, 25$3.07Sep 9, 25$3.10Sep 11, 25$3.10Sep 16, 25$3.24Sep 18, 25$3.12Sep 22, 25$3.12Sep 24, 25$3.25Sep 26, 25$3.10Sep 30, 25$3.14Oct 2, 25$3.29Oct 6, 25$3.24Oct 8, 25$10.36Oct 10, 25$6.33Oct 14, 25$5.07Oct 16, 25$4.39Oct 21, 25$3.87Oct 23, 25$3.86Oct 27, 25$3.75Oct 29, 25$3.42Oct 31, 25$3.34Nov 4, 25$2.85Nov 6, 25$2.72Nov 10, 25$2.65Nov 12, 25$2.64Nov 14, 25$2.60Nov 18, 25$2.57Nov 20, 25$2.31Nov 25, 25$2.52Nov 28, 25$2.63Dec 2, 25$2.45Dec 4, 25$2.54Dec 8, 25$2.44Dec 10, 25$2.40Dec 12, 25$2.44Dec 16, 25$2.07Dec 18, 25$2.06Dec 22, 25$2.24Dec 24, 25$2.20Dec 29, 25$2.03Jan 2, 26$2.15Jan 6, 26$2.11Jan 8, 26$2.19Jan 12, 26$2.30Jan 14, 26$2.21Jan 16, 26$2.42Jan 21, 26$2.42Jan 23, 26$2.65Jan 27, 26$2.55Jan 29, 26$2.33Feb 2, 26$2.25Feb 4, 26$2.18Feb 9, 26$2.13Feb 11, 26$2.14Feb 13, 26$2.17Feb 18, 26$2.35Feb 20, 26$2.25Feb 24, 26$2.36Feb 26, 26$2.42Mar 2, 26$2.55Mar 4, 26$2.42Mar 6, 26$2.29Mar 10, 26$2.64Mar 12, 26$2.57Mar 17, 26$3.12Mar 19, 26$3.03Mar 23, 26$3.13Mar 25, 26$2.99Mar 27, 26$2.72Mar 31, 26$2.68Apr 2, 26$3.01Apr 7, 26$3.20Apr 9, 26$3.15Apr 13, 26$3.11Apr 15, 26$3.38Apr 17, 26$3.53Apr 22, 26$3.14Apr 24, 26$3.05Apr 28, 26$3.13Apr 30, 26$3.03May 4, 26$2.96May 6, 26$3.17May 8, 26$3.07May 12, 26$3.02May 14, 26$3.11May 18, 26$2.93May 20, 26$2.84May 22, 26$3.03May 28, 26$3.08Jun 1, 26$3.31Jun 3, 26$3.34Jun 5, 26$3.09Jun 9, 26$3.08Jun 11, 26$3.00Jun 15, 26$3.24Jun 17, 26$3.01Jun 22, 26$2.94Jun 24, 26$2.90Jun 26, 26$2.95Jul 2, 26$2.77
$2.0252-week range$10.36
Loading valuation history…

Fundamentals

Key fundamentals

$5.9M

Market cap

19.0%

Revenue growth (YoY)

100.0%

Gross margin

-$2.3M

Free cash flow (USD)

-$7.9M

Net debt

Net cash position

10.4%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$3.0MFY 2017$7.6MFY 2018$0.00FY 2019$17.1KFY 2020$436.9KFY 2021$1.2MFY 2022$1.7MFY 2023$2.5MFY 2024$2.5MFY 2025$3.0M
$3M$3M

Free cash flow by year

2016 → 2025

FY 2016$-8.8MFY 2017$1.5MFY 2018$-6.5MFY 2019$-6.4MFY 2020$-4.3MFY 2021$-4.7MFY 2022$-5.1MFY 2023$-4.1MFY 2024$-2.8MFY 2025$-2.3M
-$8.8M-$2.3M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 12, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventEarnings ReleaseMay 13, 2026Filing
  • Quarterly report10-Q FiledMay 12, 2026Filing
  • 8-K eventRestricted Stock AwardApr 24, 2026Filing
  • Annual report10-K FiledApr 24, 2026Filing

Questions

Frequently asked questions

What is Xenetic Biosciences, Inc.'s market cap?

Xenetic Biosciences, Inc. (XBIO) has a market capitalization of $5.9M.

What is XBIO's P/E ratio?

A meaningful P/E ratio is not available for XBIO — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is XBIO's price-to-book (P/B) ratio?

XBIO trades at 0.80 times book value per share.

Are insiders buying XBIO stock?

SEC Form 4 filings show no open-market insider buys at Xenetic Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CELZ

Creative Medical Technology Holdings, Inc.

$5.9M

RADX

Radiopharm Theranostics Limited

$5.8M

EVGN

Evogene Ltd.

$6.1M

XTLB

XTL Biopharmaceuticals Ltd.

$5.7M

APRE

Aprea Therapeutics, Inc.

$6.1M

NITO

N2OFF, Inc.

$5.5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.